The proportions of CD4+CD39+ and CD8+ T regulatory cells, important for preventing autoimmune disease, are decreased in these patients (Lan et al., 2006; Bernuzzi et al., 2010) and CD4 + CD39+ cells are significantly reduced in the PBMCs of these patients compared to healthy controls. This evidence concerns the gene CD4 and autoimmune disease.